Gene · 2817
Papers2,608
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,608
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Review on Metal-Based Theranostic Nanoparticles for Cancer Therapy and Imaging. | Technol Cancer Res Treat | 2023 | 37642945 | PubTator, text mining | PubMed |
| Precise Identification and Profiling of Surface Proteins of Ultra Rare Tumor Specific Extracellular Vesicle with Dynamic Quantitative Plasmonic Imaging. | ACS Nano | 2023 | 37638659 | PubTator, text mining | PubMed |
| A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma. | Front Oncol | 2023 | 37637064 | PubTator, text mining | PubMed |
| A Multibreed Genome-Wide Association Study for Cattle Leukocyte Telomere Length. | Genes (Basel) | 2023 | 37628647 | PubTator, text mining | PubMed |
| Stochastic epithelial-mesenchymal transitions diversify non-cancerous lung cell behaviours. | Transl Oncol | 2023 | 37611490 | PubTator, text mining | PubMed |
| An extensive β1-adrenergic receptor gene signaling network regulates molecular remodeling in dilated cardiomyopathies. | JCI Insight | 2023 | 37606047 | PubTator, text mining | PubMed |
| Identification of diagnostic biomarkers via weighted correlation network analysis in colorectal cancer using a system biology approach. | Sci Rep | 2023 | 37604903 | PubTator, text mining | PubMed |
| CD44‑hyaluronan axis plays a role in the interactions between colon cancer‑derived extracellular vesicles and human monocytes. | Oncol Lett | 2023 | 37600336 | PubTator, text mining | PubMed |
| APC and P53 mutations synergise to create a therapeutic vulnerability to NOTUM inhibition in advanced colorectal cancer. | Gut | 2023 | 37591698 | PubTator, text mining | PubMed |
| SMOC-1 interacts with both BMP and glypican to regulate BMP signaling in C. elegans. | PLoS Biol | 2023 | 37590248 | PubTator, text mining | PubMed |
| Proteomic Investigation of Differential Interactomes of Glypican 1 and a Putative Disease-Modifying Variant of Ataxia. | J Proteome Res | 2023 | 37585105 | PubTator, text mining | PubMed |
| Biliary atresia is associated with polygenic susceptibility in ciliogenesis and planar polarity effector genes. | J Hepatol | 2023 | 37572794 | PubTator, text mining | PubMed |
| PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction. | Oncogene | 2023 | 37550562 | PubTator, text mining | PubMed |
| Network approach in liquidomics landscape. | J Exp Clin Cancer Res | 2023 | 37542343 | PubTator, text mining | PubMed |
| Integrated analysis of plasma proteome and cortex single-cell transcriptome reveals the novel biomarkers during cortical aging. | Front Aging Neurosci | 2023 | 37539343 | PubTator, text mining | PubMed |
| Development and validation of a copper-related gene prognostic signature in hepatocellular carcinoma. | Front Cell Dev Biol | 2023 | 37534104 | PubTator, text mining | PubMed |
| Methylated SEPT9 combined with AFP and PIVKA-II is effective for the detection of HCC in high-risk population. | BMC Gastroenterol | 2023 | 37525116 | PubTator, text mining | PubMed |
| The Shear Stress-Regulated Expression of Glypican-4 in Endothelial Dysfunction In Vitro and Its Clinical Significance in Atherosclerosis. | Int J Mol Sci | 2023 | 37511353 | PubTator, text mining | PubMed |
| Promising Highly Targeted Therapies for Cholangiocarcinoma: A Review and Future Perspectives. | Cancers (Basel) | 2023 | 37509347 | PubTator, text mining | PubMed |
| ClearF++: Improved Supervised Feature Scoring Using Feature Clustering in Class-Wise Embedding and Reconstruction. | Bioengineering (Basel) | 2023 | 37508851 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2817/papers?page=13